Reduced variation of tracer binding in digoxin radioimmunoassay by use of (125I)-labeled tyrosine-methyl-ester derivative: relation of thyroxine concentration to binding.

1976 ◽  
Vol 22 (10) ◽  
pp. 1732-1734 ◽  
Author(s):  
B H Kroening ◽  
M Weintraub

Abstract Between-sample variation in tracer binding in the 125I-labeled digoxin radioimmunoassay was investigated with two tracers, 3-O-succinyl-digoxigenin-[125I]-labeled tyrosine and [125I]-labeled tyrosine-methyl-ester-digoxin. Digoxin-free serum samples having various concentrations of thyroxine were assayed with both tracers. The percentage of tracer bound when the samples were assayed with the first-mentioned tracer was increased significantly for the low thyroxine groups when compared to the normal (P less than 0.001) or the high thyroxine groups (P less than 0.05). Little difference existed when the latter tracer was used. There was variation in tracer binding when serum from dogs dosed with thyrotropin was assayed with the first tracer, but there was little variation with the second. Tracer binding may be influenced by thyroxine-binding proteins. Variation in tracer binding appears to be reduced when [125I]-labeled tyrosine-methyl-ester-digoxin is used.

1999 ◽  
Vol 27 (6) ◽  
pp. 661-662 ◽  
Author(s):  
P. Ramesh ◽  
N. Srinivasa Reddy ◽  
T. Prabakar Rao ◽  
J. Venkateswara Rao ◽  
Y. Venkateswarlu

1978 ◽  
Vol 24 (1) ◽  
pp. 155-157 ◽  
Author(s):  
W G Kramer ◽  
N L Kinnear ◽  
H K Morgan

Abstract We evaluated four commercially available 125I-digoxin radioimmunoassay kits with regard to their ability to cross react with the digoxin metabolite dehydrodigoxin. We prepared dihydrodigoxin serum samples in digoxin-free serum over the concentration range 0.4 to 5.0 microgram/liter and assayed them with each kit according to the manufacturer's instructions. The metabolite was able to displace the 125I-labeled digoxin derivative from the antibody supplied with all four kits. However, the extent of the cross reactivity depended on the kit, ranging from essentially zero to a high degree of interference. Dihydrodigoxin is the only metabolite of digoxin to have been quantitiated in human serum, and may comprise up to 30% of total glycosides. Over the clinical and therapeutic range of serum digoxin concentrations, enough dihydrodigoxin can be produced to interfere in the determination of serum digoxin concentrations by this method. We suggest that laboratories evaluate their specific kit with regard to cross reactivity to this metabolite.


1999 ◽  
Vol 54 (5-6) ◽  
pp. 325-332 ◽  
Author(s):  
Maria Teresa Gutiérrez-Lugo ◽  
Blas Lotina-Hennsen ◽  
Amelia Farrés ◽  
Sergio Sánchez ◽  
Rachel Mata

Abstract The polyether antibiotic maduramicin and its methyl ester derivative inhibited photophos­ phorylation and proton uptake in isolated spinach chloroplasts. Both compounds also en­ hanced basal and phosphorylating electron transport and stimulated Mg2+-dependent AT­ Pase activity, therefore, they behave as uncouplers of photophosphorylation being the methyl ester derivative more potent than the parent compound. On the other hand, maduramicin inhibited germination and radicle elongation of several crop and weed species. In addition, the antibiotic caused phytotoxic injury and fresh weight reduction to 4-to-6 week old seed­ lings of two weed and two crop species when applied at 10-4 ᴍ by foliar application in the greenhouse.


2004 ◽  
Vol 31 (5) ◽  
pp. 655-662 ◽  
Author(s):  
Roberta Visentin ◽  
Maria Cecilia Giron ◽  
Michele Bello ◽  
Ulderico Mazzi

1993 ◽  
Vol 37 (3) ◽  
pp. 419-428 ◽  
Author(s):  
K R Reuhl ◽  
M Vapiwala ◽  
M T Ryzlak ◽  
C P Schaffner

2005 ◽  
Vol 28 (12) ◽  
pp. 2206-2210 ◽  
Author(s):  
Su-Hui Chao ◽  
An-Bang Wu ◽  
Chia-Jung Lee ◽  
Fu-An Chen ◽  
Ching-Chiung Wang

Sign in / Sign up

Export Citation Format

Share Document